EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination

Jill K Jones, Hengshan Zhang, Anne-Marie Lyne, Florence M G Cavalli, Wafa E Hassen, Kevin Stevenson, Reb Kornahrens, Yuanfan Yang, Sean Li, Samuel Dell, Zachary J Reitman, James E Herndon und 3 weitere

Neuro-Oncology Advances · 01.01.2023 · 5 (1)

DOI: 10.1093/noajnl/vdad095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 07.08.2023. Verfasst von Jill K Jones und 14 weiteren Autor:innen. Beteiligte Einrichtung: Harvard/MIT MD-PhD Program, Boston, MA, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medulloblastoma is the most common malignant pediatric brain tumor, and leptomeningeal dissemination (LMD) of medulloblastoma both portends a poorer prognosis at diagnosis and is incurable at recurrence. The biological mechanisms underlying LMD are unclear. The Abelson (ABL) tyrosine kinase family members, ABL1 and ABL2, have been implicated in cancer cell migration, invasion, adhesion, metastasis, and chemotherapy resistance, and are upstream mediators of the oncogene c-MYC in fibroblasts and lung cancer cells. However, their role in medulloblastoma has not yet been explored. The purpose of this work was to elucidate the role of ABL1/2 in medulloblastoma LMD.

Methods

ABL1 and ABL2 mRNA expression of patient specimens was analyzed. shRNA knockdowns of ABL1/2 and pharmacologic inhibition of ABL1/2 were used for in vitro and in vivo analyses of medulloblastoma LMD. RNA sequencing of ABL1/2 genetic knockdown versus scrambled control medulloblastoma was completed.

Results

ABL1/2 mRNA is highly expressed in human medulloblastoma and pharmacologic inhibition of ABL kinases resulted in cytotoxicity. Knockdown of ABL1/2 resulted in decreased adhesion of medulloblastoma cells to the extracellular matrix protein, vitronectin (P = .0013), and significantly decreased tumor burden in a mouse model of medulloblastoma LMD with improved overall survival (P = .0044). Furthermore, both pharmacologic inhibition of ABL1/2 and ABL1/2 knockdown resulted in decreased expression of c-MYC, identifying a putative signaling pathway, and genes/pathways related to oncogenesis and neurodevelopment were differentially expressed between ABL1/2 knockdown and control medulloblastoma cells.

Conclusions

ABL1 and ABL2 have potential roles in medulloblastoma LMD upstream of c-MYC expression.

Schlagwörter

Stichwörter der Autor:innen

ABL1ABL2c-MYCmedulloblastomametastases

Autor:innen und Institutionen

  • Harvard/MIT MD-PhD Program, Boston, MA, USA.
  • Department of Neurosurgery, Duke University, Durham, NC, USA.
  • Institut Curie, PSL Research University, Paris, France.
  • Inserm, U900, Paris, France.
  • MINES ParisTech, CBI - Centre for Computational Biology, PL Research University, Paris, France.
  • Duke University Molecular Physiology Institute, Durham, NC, USA.

ORCID-Profile: Eric M Thompson

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Jones, J. K., Zhang, H., Lyne, A. M., Cavalli, F. M. G., Hassen, W. E., Stevenson, K., Kornahrens, R., Yang, Y., Li, S., Dell, S., Reitman, Z. J., Herndon, J. E., Hoj, J., Pendergast, A. M., & Thompson, E. M. (2023). ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination. Neuro-Oncology Advances, 5(1). https://doi.org/10.1093/noajnl/vdad095

Vancouver

Jones JK, Zhang H, Lyne AM, Cavalli FMG, Hassen WE, Stevenson K, et al. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination. Neuro-Oncology Advances. 2023;5(1). doi:10.1093/noajnl/vdad095

BibTeX
@article{Jones2023,
  author = {Jones, Jill K and Zhang, Hengshan and Lyne, Anne-Marie and Cavalli, Florence M G and Hassen, Wafa E and Stevenson, Kevin and Kornahrens, Reb and Yang, Yuanfan and Li, Sean and Dell, Samuel and Reitman, Zachary J and Herndon, James E and Hoj, Jacob and Pendergast, Ann Marie and Thompson, Eric M},
  title = {ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination},
  journal = {Neuro-Oncology Advances},
  year = {2023},
  volume = {5},
  number = {1},
  doi = {10.1093/noajnl/vdad095}
}
Kostenlos starten →